What are the current guidelines for administering Iloprost infusions in patients with severe Raynaud's Phenomenon?
Iloprost infusions are a recommended treatment for severe Raynaud's Phenomenon, especially after failure of oral therapies. They are administered at doses of 0.5-2.0 ng/kg/min over several days, requiring monitoring for vasodilatory side effects.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.5281/zenodo.24155818
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00